Veronica Trevino Garcia
Family · San Antonio, TXNPI 1477706794
Payments from drug & device makers
Across 187 payments — averaging $26.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Sanofi$844
- Genentech USA, Inc.$519
- Sanofi-aventis U.S. LLC$425
- AstraZeneca$412
- Grifols USA, LLC$126
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,87299%
- Education$681%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 65 | $1,386 |
| Sanofi | 19 | $844 |
| Genentech USA, Inc. | 15 | $519 |
| Sanofi-aventis U.S. LLC | 14 | $425 |
| AstraZeneca | 18 | $412 |
| Grifols USA, LLC | 6 | $126 |
| Blueprint Medicines Corporation | 2 | $124 |
| Alk-abello, Inc | 7 | $124 |
| Novo Nordisk | 1 | $120 |
| Novartis | 6 | $110 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $98 |
| Amgen | 6 | $96 |
| Octapharma USA, Inc. | 5 | $90 |
| Kaleo, Inc. | 4 | $80 |
| Pfizer | 3 | $67 |
| Incyte Corporation | 3 | $63 |
| Baxter Healthcare | 2 | $45 |
| Covis Pharma GmbH | 2 | $39 |
| Hikma Pharmaceuticals USA | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,940 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 23 | $78,810 |
| TezspireTezepelumab-Ekko | 19 | $77,806 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $59,122 |
| Dupixent PenDupilumab | 14 | $50,190 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $15,550 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $9,365 |
| AlvescoCiclesonide | 14 | $3,963 |
| Mometasone Furoate | 24 | $3,345 |
| Epinephrine | 15 | $2,741 |
| Azelastine Hcl | 64 | $2,654 |
| Fluticasone Propionate | 104 | $2,189 |
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $1,801 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,600 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $1,447 |
| Montelukast Sodium | 67 | $926 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaTezspire, Breztri Aerosphere | $412 | $87,17131 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,386 | $74,67270 claims |
| Covis Pharma GmbHAlvesco | $39 | $3,96314 claims |
| Hikma Pharmaceuticals USAEpinephrine | $37 | $2,74115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 15,456 family providers in Texas.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.